Pfs25 malaria vaccine (MVI)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePfs25 malaria vaccine (MVI)
Drug Alias NamePfs25 antigenPfs25疟疾疫苗Transmission-blocking malaria vaccinePfs25-EPA/AlhydrogelMalaria transmission-blocking Pfs25-Pfs25 conjugate vaccine +[9] 
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMali
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins Bloomberg School Of Public HealthSabin Vaccine InstituteMalaria Vaccine Initiative
China Registration ClassN/A

Develop Information

Active CompaniesFraunhofer Usa Center For Molecular BiotechnologySabin Vaccine InstituteMalaria Vaccine Initiative +[5] 
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human Development
Active IndicationsMalaria
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A